复发性肝细胞癌的治疗:目前的标准和未来的前景
Mohammed Omar Khalifa Elsayed1
1Department of Gastroenterology, South Tees Hospitals NHS Foundation Trust, The James Cook University Hospital, Middlesbrough TS4 3BW, United Kingdom. dmohammed_omar_76@outlook.com.
World journal of gastrointestinal oncology
|November 24, 2025
概括
肝细胞癌复发 (RHCC) 管理缺乏明确的指导方针,由于肝脏储备较小,这带来了挑战. 本综述探讨了当前的RHCC治疗标准和未来的方向.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
背景情况:
- 肝细胞癌 (HCC) 是一种流行癌症,存活率较低.
- 增加的肝病,包括非酒精性脂肪肝病,推动了HCC发病率的上升.
- 反复性HCC (RHCC) 管理缺乏标准化指导方针,与初级HCC不同.
研究的目的:
- 对复发性HCC (RHCC) 的当前管理策略进行审查.
- 讨论管理RHCC的挑战,特别是在肝脏手术或移植后.
- 探索RHCC治疗的未来前景.
主要方法:
- 对RHCC管理当前标准的文献综述.
- 对初级HCC的治疗方式的分析及其对RHCC的适用性.
- 讨论与RHCC病例中肝脏体积和功能的减少有关的挑战.
主要成果:
- 对于最佳的RHCC管理,没有达成共识.
- 对RHCC的治疗决定是复杂的,考虑到先前的治疗和剩余的肝功能.
- 现有的初级HCC治疗可能在RHCC中发挥作用,但其疗效尚不清楚.
结论:
- 对于复发性HCC (RHCC) 治疗,迫切需要标准化指南.
- 需要进一步的研究来澄清各种治疗方式在RHCC中的作用.
- 未来的策略可能涉及量身定制的方法,考虑个体患者的因素和新疗法.
更多相关视频
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
9.4K
09:11Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
1.0K
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Chronic Pancreatitis II: Collaborative Care
296
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
296
